Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
KROS · against 596 other Healthcare companies listed in US-listed
Ranked #60 of 597 · scores higher than 90% of peers · safety percentile 94
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)104 peers with a safety percentile of 90–100, including KROS · Click a bar to see the companies
Mainly thanks to its current ratio and debt / equity, which are stronger than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | KROS | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 523 reported | 0.06× | 0.23× | 69% | 33% | |
| BetaLower is better · 556 reported | 1.12 | 0.95 | 40% | 33% | |
| Current ratioHigher is better · 600 reported | 21.96× | 3.91× | 94% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 186M USD | 100 | 52 | |
| 4 | 1.5B USD | 100 | 44 | |
| 5 | 1.2B USD | 100 | 40 | |
| 56 | 1.0B USD | 94 | 32 | |
| 57 | 549M USD | 94 | 30 | |
| 58 | 3.9B USD | 94 | 52 | |
| 59 | 1.5B USD | 94 | 93 | |
| 60 | 215M USD | 94 | 34 | |
| 61 | 5.2B USD | 94 | 74 | |
| 62 | 274M USD | 94 | 57 | |
| 63 | 256M USD | 94 | 80 | |
| 64 | 1.4B USD | 94 | 38 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score